(NASDAQ:NUWE), MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum today announced that the United States Patent and Trademark Office recently issued a new U.S. patent covering advanced safety mechanisms for blood return line clamps used in extracorporeal blood filtration […]

(NASDAQ:ERNA), Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on track to initiate first-in-human (FIH) trial for the treatment of ovarian cancer in the second half of 2026 CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the

EAB Acquires Hybrid to Expand Global Reach and Enhance Digital Innovation Hybrid's AI-powered digital and creative capabilities will strengthen how colleges connect with learners worldwide GlobeNewswire January 06, 2026 Washington, D.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Education company EAB announced today that it has acquired Hybrid, a UK-based leader in digital marketing for higher

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy Patent issuance strengthens pediatric intellectual property portfolio and advances system-level safety design GlobeNewswire January 06, 2026 MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum

Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer GlobeNewswire January 06, 2026 Regulatory alignment supports rapid progress, tech transfer already underway to accelerate clinical readiness Company on track to initiate first-in-human (FIH) trial for the treatment of ovarian cancer in the second half of 2026 CAMBRIDGE, Mass.,

Chico, California–(Newsfile Corp. – January 6, 2026) – AmeraMex International, Inc. (OTC Pink: AMMX), a premier provider of new and refurbished heavy equipment for the logistics, construction, and industrial markets, today announced it has received new equipment orders totaling approximately $450,000. The orders consist of mostly refurbished equipment and include two LiuGong forklifts, one with

(NYSE:ARE), NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential

Alexandria Real Estate Equities, Inc. (ARE) Impairment Charge Triggers Securities Fraud Class Action – Contact BFA Law before January 26 Court Deadline GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria

(NASDAQ:VIVS), SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (“3D”) human tissue models of liver and intestine, announces it has appointed Amar Sethi, M.D., Ph.D. as

24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business How Decades of Innovation Are Converging for Commercial Spider Silk Success GlobeNewswire January 06, 2026 DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft